Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

ECVAM Good Cell Culture Practice Task Force Report 1

ECVAM Good Cell Culture Practice Task Force Report 1 ATLA 30, 407–414, 2002 407 Good Cell Culture Practice 1 2 3,4 5 2 Thomas Hartung, Michael Balls, Claudia Bardouille, Olivier Blanck, Sandra Coecke, 6 3 Gerhard Gstraunthaler and David Lewis 1 2 Biochemical Pharmacology, University of Konstanz, 78457 Konstanz, Germany; ECVAM, Institute for Health & Consumer Protection, European Commission Joint Research Centre, 21020 Ispra (VA), Italy; European Collection of Animal Cell Cultures, Centre for Applied Microbiology & Research, Porton Down, Salisbury SP4 0JG, UK; Pfizer Central Research, Amboise, Poce-sur Cisse, 37401 Amboise, France; Institute of Physiology, University of Innsbruck, Innsbruck, Austria condition for the publication of work involving Background cell and tissue culture. This statement should be reviewed and updated at further World The maintenance of high standards is fundamental to Congresses on Alternatives and Animal Use in all good scientific practice, and is essential for ensur- ing the reproducibility, reliability, credibility, accept- the Life Sciences.” ance and proper application of any results produced. These initiatives resulted from recognition of the The aim of this Good Cell Culture Practice (GCCP) initiative is to reduce uncertainty in the development rapidly expanding use of in vitro systems, not only in basic research, but also to meet regulatory and application of http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Alternatives to Laboratory Animals SAGE

ECVAM Good Cell Culture Practice Task Force Report 1

Download PDF
8 pages

Loading next page...
 
/lp/sage/ecvam-good-cell-culture-practice-task-force-report-1-umTEIe00Ev

References (33)

Publisher
SAGE
Copyright
© 2002 Fund for the Replacement of Animals in Medical Experiments
ISSN
0261-1929
eISSN
2632-3559
DOI
10.1177/026119290203000404
Publisher site
See Article on Publisher Site

Abstract

ATLA 30, 407–414, 2002 407 Good Cell Culture Practice 1 2 3,4 5 2 Thomas Hartung, Michael Balls, Claudia Bardouille, Olivier Blanck, Sandra Coecke, 6 3 Gerhard Gstraunthaler and David Lewis 1 2 Biochemical Pharmacology, University of Konstanz, 78457 Konstanz, Germany; ECVAM, Institute for Health & Consumer Protection, European Commission Joint Research Centre, 21020 Ispra (VA), Italy; European Collection of Animal Cell Cultures, Centre for Applied Microbiology & Research, Porton Down, Salisbury SP4 0JG, UK; Pfizer Central Research, Amboise, Poce-sur Cisse, 37401 Amboise, France; Institute of Physiology, University of Innsbruck, Innsbruck, Austria condition for the publication of work involving Background cell and tissue culture. This statement should be reviewed and updated at further World The maintenance of high standards is fundamental to Congresses on Alternatives and Animal Use in all good scientific practice, and is essential for ensur- ing the reproducibility, reliability, credibility, accept- the Life Sciences.” ance and proper application of any results produced. These initiatives resulted from recognition of the The aim of this Good Cell Culture Practice (GCCP) initiative is to reduce uncertainty in the development rapidly expanding use of in vitro systems, not only in basic research, but also to meet regulatory and application of

Journal

Alternatives to Laboratory Animals – SAGE

Published: Jul 1, 2002

There are no references for this article.